Parkwood LLC Travere Therapeutics, Inc. Transaction History

Parkwood LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $26,929 - $38,112	1,458 Added 9.56%	16,704 $351,000
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $12,188 - $15,231	532 Added 3.62%	15,246 $376,000
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $62,464 - $89,519	-2,983 Reduced 16.86%	14,714 $15,000
Q1 2022 May 13, 2022	BUY	$23.61 - $30.6 $417,826 - $541,528	17,697 New	17,697 $456,000

203

85.2M

776K

912K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.4B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.